IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BOSSI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.741
AS - Asia 9.813
EU - Europa 5.385
SA - Sud America 2.192
Continente sconosciuto - Info sul continente non disponibili 418
AF - Africa 231
OC - Oceania 23
Totale 35.803
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.323
SG - Singapore 3.257
CN - Cina 2.539
HK - Hong Kong 1.909
BR - Brasile 1.828
UA - Ucraina 887
IT - Italia 838
VN - Vietnam 710
DE - Germania 620
FR - Francia 395
PL - Polonia 395
IE - Irlanda 391
TR - Turchia 389
RU - Federazione Russa 384
GB - Regno Unito 380
FI - Finlandia 328
EE - Estonia 295
IN - India 212
BD - Bangladesh 207
CA - Canada 187
AR - Argentina 147
ID - Indonesia 128
SE - Svezia 109
MX - Messico 104
IQ - Iraq 84
AT - Austria 83
ZA - Sudafrica 81
NL - Olanda 69
EC - Ecuador 63
PK - Pakistan 54
JP - Giappone 50
SA - Arabia Saudita 45
CO - Colombia 44
CZ - Repubblica Ceca 44
ES - Italia 44
EG - Egitto 39
VE - Venezuela 34
JM - Giamaica 31
MA - Marocco 29
PY - Paraguay 26
UZ - Uzbekistan 26
CH - Svizzera 24
NP - Nepal 22
CR - Costa Rica 21
JO - Giordania 21
AU - Australia 20
MY - Malesia 20
PE - Perù 18
CL - Cile 17
KE - Kenya 17
IL - Israele 16
AZ - Azerbaigian 15
HN - Honduras 14
BE - Belgio 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
LT - Lituania 12
IR - Iran 11
KZ - Kazakistan 11
PH - Filippine 11
DO - Repubblica Dominicana 10
NI - Nicaragua 10
DZ - Algeria 9
AL - Albania 8
ET - Etiopia 8
OM - Oman 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
BH - Bahrain 7
LY - Libia 7
MD - Moldavia 7
PA - Panama 7
SN - Senegal 7
UY - Uruguay 7
BB - Barbados 6
GT - Guatemala 6
HR - Croazia 6
LB - Libano 6
MK - Macedonia 6
PT - Portogallo 6
AO - Angola 5
DK - Danimarca 5
KG - Kirghizistan 5
KR - Corea 5
BG - Bulgaria 4
BO - Bolivia 4
EU - Europa 4
GR - Grecia 4
LK - Sri Lanka 4
MT - Malta 4
MU - Mauritius 4
SK - Slovacchia (Repubblica Slovacca) 4
AG - Antigua e Barbuda 3
BY - Bielorussia 3
GE - Georgia 3
GY - Guiana 3
KW - Kuwait 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RO - Romania 3
Totale 35.339
Salva come PNG Salva come JPEG
Città #
Fairfield 2.232
Hong Kong 1.900
Ashburn 1.728
Singapore 1.565
Seattle 924
Woodbridge 899
Jacksonville 851
Houston 801
The Dalles 756
Cambridge 696
Wilmington 674
San Jose 653
Princeton 636
Beijing 573
Council Bluffs 515
Dallas 505
New York 475
Chandler 416
Warsaw 387
Dublin 347
Istanbul 323
Lauterbourg 303
Los Angeles 297
Tallinn 295
Ann Arbor 282
Helsinki 257
Ho Chi Minh City 207
Des Moines 172
Nanjing 163
San Diego 153
Redondo Beach 151
São Paulo 139
Hanoi 134
Brescia 127
Buffalo 126
Santa Clara 119
Chicago 112
Milan 105
Columbus 104
Moscow 104
London 98
Munich 98
San Francisco 86
Jakarta 85
Shanghai 85
Changsha 79
Nuremberg 77
Shenyang 75
Brooklyn 62
Tianjin 61
Rome 59
Dong Ket 58
Jinan 58
Nanchang 57
Orem 57
Hebei 52
Jiaxing 52
Frankfurt am Main 50
Johannesburg 47
Toronto 47
Menlo Park 43
Tokyo 43
Guangzhou 42
Montreal 42
Rio de Janeiro 42
Pune 41
Hangzhou 40
Phoenix 40
Belo Horizonte 38
Denver 37
Turku 37
Atlanta 35
Brasília 35
Chennai 35
Curitiba 35
Vienna 34
Brno 33
Haiphong 33
Salt Lake City 33
Baghdad 29
Las Vegas 29
Fortaleza 28
Mexico City 28
Zhengzhou 28
Boston 27
Campinas 27
Da Nang 27
Lappeenranta 27
Ningbo 27
Kilburn 26
Manchester 26
Boardman 25
Salvador 25
Cairo 24
Poplar 23
Norwalk 22
Stockholm 22
Taizhou 21
Washington 21
Amman 20
Totale 23.799
Salva come PNG Salva come JPEG
Nome #
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 815
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 448
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 354
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 243
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 231
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 226
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 214
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 213
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 205
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 199
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 194
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 191
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 190
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 186
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 179
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 176
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 168
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 166
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 165
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 163
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 161
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 159
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 156
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 156
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 155
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 154
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 153
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 148
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 147
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 145
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 144
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 142
Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group 140
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 140
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 140
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 139
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 137
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 137
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 136
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment 135
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 135
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 135
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 135
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 135
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 133
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 133
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 132
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 132
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 132
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 129
Investigational drugs for head and neck cancer 129
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 128
The role of systemic therapy in the management of sinonasal cancer: A critical review 127
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 126
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 125
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 123
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group 123
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 122
Multikinase inhibitors in thyroid cancer 122
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 122
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 122
Hope in cancer patients: the relational domain as a crucial factor 121
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases 121
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study 121
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 120
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 120
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 120
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 119
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 119
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System 118
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 118
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 118
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 118
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma 118
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 117
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 117
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 117
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 116
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 116
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 116
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 116
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 116
Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial 116
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 115
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 115
New insights in chemotherapy 115
Emerging tyrosine kinase inhibitors for head and neck cancer 115
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 115
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 114
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 114
TP53 mutations in head and neck cancer 114
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 114
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 113
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study 113
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 112
The Case Volume Issue in Head and Neck Oncology 112
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 111
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 111
Pain related to cancer treatments and diagnostic procedures: a no man's land? 111
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 111
Totale 15.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 217.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.968 0 0 56 283 109 212 76 202 120 195 201 514
2022/20231.518 359 89 46 113 92 464 8 96 144 26 37 44
2023/20242.385 64 36 117 107 122 577 90 137 665 39 33 398
2024/20255.799 32 21 69 1.028 543 536 336 134 730 555 1.132 683
2025/202612.265 1.063 2.379 1.309 1.712 773 632 1.471 462 715 1.042 495 212
2026/20271.616 621 632 363 0 0 0 0 0 0 0 0 0
Totale 35.803